There were 1,890 press releases posted in the last 24 hours and 398,228 in the last 365 days.

Turning Biorepositories into Translational Science Treasure Troves, New Webinar Hosted by Xtalks

The Value of Uniquely Complete Data Sets, Put All Your Specimens -- and All of Their Data -- At Your Fingertips System

Covance logoCovance is one of the world's largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion and more than 12,000 employees in more than 60 countries.Click here for high-resolution version

/EINPresswire.com/ -- TORONTO, ON--(Marketwired - April 24, 2017) - Industry expert Dr. Amelia Warner, Founder of Global Specimen Solutions Inc. will provide insight on how their alliance can bring new insights to your research, using a fully-outsourced SaaS platform designed from the ground up to accommodate not just a few trials' worth of data, but entire pipelines for rich answers in real time. Completely sidestep software development costs and start turning your ideas into tomorrow's healthcare solutions.

With a steady increase in the number of biomarker assays available for use in clinical trials, and improved logistics capabilities opening wider patient populations around the globe, the pharmaceutical industry's trial specimen biorepositories represent an increasingly valuable resource for translational science.

However, numerous challenges interfere with achieving this reality. These include identifying and locating relevant specimens, and obtaining complete records, such as result information and informed consent. The problem is simple: the necessary data isn't available in a timely fashion and these delays are impeding decision making at a time when competitive pressures demand quick answers and actionable insights.

Pharma has tried, and often failed, to solve this problem. Stories abound about internal initiatives to create holistic data management systems, but success requires a wide range of expertise and capability outside of pharma's core mission of discovery and commercialization. Internally-designed informatics systems struggle from cost overruns in development and data entry, without delivering on their promise.

Success in modern translational medicine requires a scalable approach to transcend the data silos, enabling unified views of specimen data through real-time analytics; yielding a nimble approach that meets the immediate clinical trial needs and provides pan-pipeline insights.

Covance and Global Specimen Solutions, Inc. (GSS) have formed a unique strategic alliance, offering new solutions for extracting value from the entire specimen life cycle. Using the power of GlobalCODE® from GSS, coupled with the global operational expertise and scientific depth of Covance, we are able to offer the SpecimINSIGHT™ solution to our clients.

Join Dr. Amelia Warner on Thursday, May 4, 2017 at 11am EDT (4pm BST/UK). For more information or to register for this complimentary event, visit: Turning Biorepositories into Translational Science Treasure Troves: The Value of Uniquely Complete Data Sets

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2017/4/21/11G136610/Images/Logo-78a2a55d48a5b7f2bafede18bb9d3e67.jpg

Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com